All About the Journey
A reflection on my time with Pharma Commerce thus far, and a plan of action for moving the brand forward.
I was reflecting on my career thus far here at Pharmaceutical Commerce when I realized that this month marks my three-year anniversary with the publication, having been brought on as an associate editor at the height of the COVID-19 pandemic in October 2020.
Fortunately for me, Pharma Commerce’s parent company, MJH Life Sciences, was hiring and had just completed the acquisition of the magazine a few months prior. I was “thrown into the fire,” as the saying goes, and began a new chapter of my career under the tutelage of Mike Christel, now our group managing editor.
Throughout my time here, I have continued to make brand recognition a top priority, especially when on the road at trade shows and conferences. After all, an argument can be made for the invaluable benefit that these events provide. At August’s Healthcare Distribution Alliance (HDA) Traceability Seminar, which is covered in great length in this issue’s “Conference Connect,” I was able to chat with Gregg Gorniak of
newly-named Cencora (formerly AmerisourceBergen)—and a past guest of the PC Podcast—about other potential ways that we could collaborate in the future.
In fact, many of our subscribers may be reading this at LogiPharma USA in Boston early this month. In my experience, this event has been a magical place for networking and establishing long-term professional relationships (this year’s show marks my second on the American front after attending France’s LogiPharma Europe in April).
Nick Basta, Pharma Commerce's editor emeritus and founder, was the face of the brand for many years, and industry vendors and editorial contributors alike have long associated him with the publication. As we evolve the brand forward, now three years on, I plan to continue to stress our development.
In fact, behind the scenes, we have been in the midst of a rebrand, working closely with our talented colleagues in creative and sales. The main focus is on providing both a cleaner and fresher look to not only the print issues, but the website as well. If I were to describe what we have in the works, it would be bold. Once these updates go live, I look forward to receiving your feedback to help us further improve and "enhance."
I hope you enjoy this month’s issue and I look forward to meeting many of you at LogiPharma USA!
Understanding the FDA's Exemption for DSCSA Compliance
November 12th 2024In the quest for achieving full traceability, the exemption applies to certain trading partners under the Act, and postpones enforcement of final compliance requirements while acknowledging progress and ongoing challenges.
